Bone Healing Implant Substrates With Dual Oxygen-Modulating Compositions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bone fractures and segmental defects, such as autologous and allogeneic bone grafts and recombinant human bone morphogenetic proteins, face challenges including limited availability, donor site morbidity, and significant side effects, while the inability to predict fracture healing outcomes leads to delayed or non-union issues, imposing a clinical and economic burden.
Innovation Solution
Devices comprising an implantable substrate with a first active composition for bone union and a second active composition for oxygen modulation, including erythropoietin and oxygen-modulating agents like anti-CD-71 antibodies, are used to enhance bone healing by recruiting erythroid lineage cells and modulating oxygen levels at the fracture site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous bone grafts are used, then bone healing is improved, but donor site morbidity and limited availability occur
Solution Approach 1:
The invention separates the bone graft material into demineralized bone matrix particles (providing osteoinductive factors) and a separate scaffold structure (提供机械支撑), allowing the biological active components to be delivered without requiring large amounts of donor bone tissue
Solution Approach 2:
The scaffold acts as an intermediary carrier that delivers osteoinductive factors to the fracture site, mediating between the bone morphogenetic proteins and the bone healing process, while providing mechanical support and facilitating vascular invasion
2Quantity of substance
If allogeneic bone grafts are used, then availability is improved, but revitalization failure occurs
Solution Approach 1:
The invention changes the physical and chemical parameters of the bone graft material by demineralizing it to create pores and increase surface area, transforming it from a structurally intact but biologically inactive allograft into a highly osteoinductive material that reliably stimulates bone formation
Solution Approach 2:
The invention creates a composite material combining demineralized bone matrix (providing osteoinductive growth factors) with a scaffold structure (提供机械支撑 and porosity), achieving both availability and reliable revitalization
3Reliability
If rhBMP-2 is used, then bone formation is improved, but side effects increase
Solution Approach 1:
The invention applies osteoinductive factors locally to the fracture site through the scaffold structure, concentrating the biological activity exactly where needed for bone formation, thereby reducing systemic side effects and heterotopic ossification while maintaining effective local bone formation
Solution Approach 2:
The use of porous demineralized bone matrix allows for controlled local delivery of osteoinductive factors, enabling bone formation enhancement while minimizing the dosage required and reducing the risk of side effects associated with higher doses of recombinant BMP-2
4Ease of manufacture
If standard bone graft procedures are used, then treatment is provided, but healing time is extended
Solution Approach 1:
The scaffold is pre-formed with optimal porosity and structure before implantation, and osteoinductive factors are pre-loaded or pre-concentrated in the demineralized bone matrix, enabling immediate action upon implantation and accelerating the bone healing process without requiring additional surgical steps
Solution Approach 2:
The invention changes the porosity and surface area parameters of the bone graft material through demineralization, creating a structure that dramatically enhances cellular infiltration, vascular invasion, and osteoblast recruitment, thereby reducing healing time while maintaining procedural simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The devices significantly reduce the incidence of non-union and enhance bone healing by increasing bone volume and reducing healing time, achieving up to 100% bone union in most cases, compared to standard procedures.
Implementation Method 1
Devices and methods for bone fracture and segmental defect healing that modulate erythropoiesis and oxygen levels at the fracture site
Implementation Method 2
a second active composition for oxygen modulation, including erythropoietin and oxygen-modulating agents like anti-CD-71 antibodies
Data Source
AI summary
Provided herein are devices and methods that represent a dual function approach to tissue engineering and regenerative medicine, particularly for bone fracture or segmental defect healing. The devices include an implantable substrate; a first active composition, and a second active composition that comprises one or more oxygen-modulating compositions. The incorporation of dual bioactive compositions on the substrate offers a versatile platform for manipulating cells and modulating the local tissue oxygen environment at the site of implantation.